Christopher T Mather is an accomplished inventor based in Rocky Hill, NJ (US). He has made significant contributions to the field of clinical trial budget analysis, holding a total of 3 patents. His innovative methods have streamlined the budgeting process for clinical trials, making it more efficient and effective.

Latest Patents

Mather's latest patents include a "Method and article of manufacture for performing clinical trial budget analysis." This electronic method allows for the analysis of clinical trial budgets by inputting the budget into a processor. The budget consists of various activities and their associated costs. The activities are classified into standardized service categories, enabling the processor to allocate costs accurately. A report is generated to assist in analyzing these budgets objectively. Another patent of his is a computer-implemented method that also focuses on analyzing clinical trial budgets. It involves entering the budget into a processor, classifying activities, and calculating per unit costs of assumption specifications. This method further equalizes costs against reference specifications, enhancing the accuracy of budget analysis.

Career Highlights

Christopher T Mather is currently employed at Numoda Technologies, Inc., where he continues to develop innovative solutions for clinical trial management. His work has been instrumental in improving the efficiency of budget analysis in clinical trials.

Collaborations

Mather collaborates with talented professionals such as Ieda A Mancini and Ann S Vurimindi, contributing to a dynamic work environment that fosters innovation.

Conclusion

Christopher T Mather is a notable inventor whose work in clinical trial budget analysis has made a significant impact in the field. His patents reflect a commitment to improving the efficiency and accuracy of clinical trial budgeting processes.